Danny Brannagan - Covalon Technologies CFO

CVALF Stock  USD 0.77  0.03  3.75%   

CFO

Mr. Danny Brannagan is Chief Financial Officer of the Company. Mr. Brannagan was managing Covalon finance team since joining the company in November, 2014 since 2015.
Tenure 9 years
Phone905 568 8400
Webhttps://www.covalon.com
Brannagan is a chartered accountant and certified professional accountant, and holds a bachelor of commerce degree from Queen University. Prior to joining Covalon, Mr. Brannagan spent several years with PriceWaterhouse Coopers LLP in the tax and assurance groups advising public and private companies on taxation and financial accounting matters. Prior to joining PriceWaterhouse Coopers LLP, Mr. Brannagan was a professional football player with the Toronto Argonauts where he became the first Canadianborn quarterback to play for the Argonauts since 1969.

Covalon Technologies Management Efficiency

The company has return on total asset (ROA) of (0.161) % which means that it has lost $0.161 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3213) %, meaning that it generated substantial loss on money invested by shareholders. Covalon Technologies' management efficiency ratios could be used to measure how well Covalon Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.25 M in total debt with debt to equity ratio (D/E) of 0.08, which may suggest the company is not taking enough advantage from borrowing. Covalon Technologies has a current ratio of 9.84, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Covalon Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Covalon Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Covalon Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Covalon to invest in growth at high rates of return. When we think about Covalon Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CFO Age

MD CFAProtagenic Therapeutics
53
Alexander ArrowProtagenic Therapeutics
46
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. Covalon Tech operates under Biotechnology classification in the United States and is traded on OTC Exchange. Covalon Technologies [CVALF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Covalon Technologies Leadership Team

Elected by the shareholders, the Covalon Technologies' board of directors comprises two types of representatives: Covalon Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Covalon. The board's role is to monitor Covalon Technologies' management team and ensure that shareholders' interests are well served. Covalon Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Covalon Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Elinor Caplan, Director
Murray Miller, Independent Director
Simon Smith, Chief Ltd
John Hands, Sr. Director of Global Marketing
Kim Crooks, VP of Operations
Ron Hebert, VP Marketing
Gale Pollock, Director
Greg Leszczynski, VP HR
Jeffrey Mandel, Independent Director
Hamed Abbasian, VP Devel
Ian Brindle, Director
Elaine Zhang, VP Operations
Myrna Francis, Independent Director
Mark Doolittle, VP Sales
Joseph Cordiano, Independent Director
Valerio DiTizio, Co-Founder and Chief Science Officer
Ronald Smith, Director
Danny Brannagan, CFO
Brian Pedlar, CEO and President and Director
John Suk, Director
Gerry Arambula, Pres Ltd
Jason Gorel, Interim Officer
Abe Schwartz, Chairman of The Board, Advisor and Member of Audit Committee
Martin Bernholtz, Independent Director

Covalon Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Covalon Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Covalon Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Covalon Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Covalon Technologies will appreciate offsetting losses from the drop in the long position's value.

Moving against Covalon OTC Stock

  0.52MMM 3M Company Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Covalon Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Covalon Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Covalon Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Covalon Technologies to buy it.
The correlation of Covalon Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Covalon Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Covalon Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Covalon Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Covalon Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Covalon OTC Stock analysis

When running Covalon Technologies' price analysis, check to measure Covalon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Covalon Technologies is operating at the current time. Most of Covalon Technologies' value examination focuses on studying past and present price action to predict the probability of Covalon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Covalon Technologies' price. Additionally, you may evaluate how the addition of Covalon Technologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Please note, there is a significant difference between Covalon Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Covalon Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Covalon Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.